CN

Joseph Jao Sung

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Jao Sung. Retrieved from https://idiyas.com/inventor/joseph-jao-sung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Joseph Jao Sung: Innovator in Pharmaceutical Compositions

Introduction

Joseph Jao Sung is a notable inventor based in China. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work with organic extracts.

Latest Patents

Joseph Jao Sung holds a patent for "Compositions Comprising Organic Extracts Of Geum Japonicum Thunb Var. And The Use Thereof." This invention provides an organic extract of Geum Japonicum thunb var. (EGJ) and a pharmaceutical composition comprising the same. The organic EGJ has been identified to show potent dual effects on stimulating early growth (less than 48 hours) of new vessels both in ischemic heart muscles and in infarcted heart muscles. It also triggers myocardial regeneration in myocardial infarction, making it a potential treatment for ischemic diseases in humans and animals, including ischemic heart disease and ischemic limbs, as well as damaged myocardium associated diseases.

Career Highlights

Joseph Jao Sung is currently associated with Lead Billion Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating serious health conditions.

Collaborations

Some of his coworkers include Ming Li and John Elsby Sanderson, who contribute to the innovative environment at Lead Billion Limited.

Conclusion

Joseph Jao Sung is a dedicated inventor whose work in pharmaceutical compositions holds promise for the treatment of ischemic diseases. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…